Macrophages are an abundant component of myeloma microenvironment and protect myeloma cells from chemotherapy drug-induced apoptosis

Blood

Volumn 114, Issue 17, 2009, Pages 3625-3628

  Zheng, Yuhuan ^a   Cai, Zhen ^a,b   Wang, Siqing ^a   Zhang, Xiang ^a   Qian, Jianfei ^a   Hong, Sungyoul ^a   Li, Haiyan ^a   Wang, Michael ^a   Yang, Jing ^a   Yi, Qing ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD68 ANTIGEN;

APOPTOSIS; ARTICLE; CANCER RESISTANCE; CELL CONTACT; CELL INFILTRATION; CELL PROTECTION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MACROPHAGE; MICROENVIRONMENT; MYELOMA CELL; PRIORITY JOURNAL; PROTEIN CLEAVAGE; SIGNAL TRANSDUCTION;

EID: 70449477633     PISSN: 00064971     EISSN: 15280020     Source Type: None    
DOI: 10.1182/blood-2009-05-220285     Document Type: Article

References (10)

1. Kyle RA, Rajkumar SV. Multiple myeloma. N Engl J Med. 2004;351(18):1860-1873.
2. Dalton WS. Drug resistance and drug development in multiple myeloma. Semin Oncol. 2002; 29[suppl 17]:21-25.
3. Epstein J, Yaccoby S. Consequences of interactions between the bone marrow stroma and myeloma. Hematol J. 2003;4(5):310-314. (Pubitemid 37259347)
4. Kikuchi T, Crystal RG. Antigen-pulsed dendritic cells expressing macrophage-derived chemokine elicit Th2 responses and promote specific humoral immunity. J Clin Invest. 2001;108(6):917-927. (Pubitemid 32880300)
5. Wang S, Hong S, Yang J, et al. Optimizing immunotherapy in multiple myeloma: restoring the function of patients' monocyte-derived dendritic cells by inhibiting p38 or activating MEK/ERK MAPK and neutralizing interleukin-6 in progenitor cells. Blood. 2006;108(13):4071-4077. (Pubitemid 44913277)
6. Yang J, Qian J, Wezeman M, et al. Targeting beta2-microglobulin for induction of tumor apoptosis in human hematological malignancies. Cancer Cell. 2006;10(4):295-307. (Pubitemid 44512192)
7. Yang J, Wezeman M, Zhang X, et al. Human C-reactive protein binds activating Fcgamma receptors and protects myeloma tumor cells from apoptosis. Cancer Cell. 2007;12(3):252-265. (Pubitemid 47333419)
8. Yaccoby S, Wezeman MJ, Henderson A, et al. Cancer and the microenvironment: myelomaosteoclast interactions as a model. Cancer Res. 2004;64(6):2016-2023. (Pubitemid 38339448)
9. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002; 23(11):549-555. (Pubitemid 35223554)
10. Klein B, Zhang XG, Jourdan M, et al. Interleukin-6 is the central tumor growth factor in vitro and in vivo in multiple myeloma. Eur Cytokine Netw. 1990;1(4):193-201.